Browse Tag

Johnson & Johnson vaccine

J&J COVID-19 vaccine pause ends

4 mins read

The FINANCIAL -- On Friday, April 23, the Advisory Committee on Immunization Practices (ACIP), an independent immunization advisory group for the Centers for Disease Control and Prevention, voted to resume distribution of the Johnson & Johnson (J&J) COVID-19 vaccine after a 10-day pause to investigate reported cases of rare blood clotting events in recipients, Mayo Clinic notes.…

Read More »

J&J COVID-19 vaccine pause ends

4 mins read

The FINANCIAL -- On Friday, April 23, the Advisory Committee on Immunization Practices (ACIP), an independent immunization advisory group for the Centers for Disease Control and Prevention, voted to resume distribution of the Johnson & Johnson (J&J) COVID-19 vaccine after a 10-day pause to investigate reported cases of rare blood clotting events in recipients, Mayo…

Science shows that you still need to wear a mask and the vaccines won’t alter your DNA

3 mins read

The FINANCIAL -- With the U.S. Food and Drug Administration announcing emergency use authorization for the Johnson & Johnson single-dose COVID-19 vaccine, UCLA Health experts are continuing to share medically sound, evidence-based information about the safety and effectiveness of all of the vaccines.…

Johnson & Johnson invests $100 mln to to eliminate health inequities for people of color

7 mins read

The FINANCIAL — Johnson & Johnson announced million in commitments and collaborations over the next five years to invest in and promote health equity solutions for Black people and other communities of color in the United States. Society has been significantly impacted by systemic racism, the COVID-19 pandemic, and the economic decline throughout this year,…

Johnson & Johnson Initiates second global Phase 3 clinical trial of its Janssen COVID-19 vaccine candidate

3 mins read

The FINANCIAL — The Phase 3 ENSEMBLE study of the single-dose regimen of JNJ-78436735, the investigational vaccine candidate for the prevention of COVID-19 being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, continues to enroll and vaccinate study participants. ENSEMBLE is proceeding to enroll up to 60,000 participants worldwide. In addition to the…